series-c-plus
Stage
2007
Founded
3
Investors
About
SphingoTec develops and markets in vitro diagnostic (IVD) tests for acute medical conditions such as sepsis, acute heart failure, and acute kidney injury. Their proprietary biomarkers provide actionable information for critical care settings.
Explore SphingoTec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.